glp 1 receptor antagonist GLP-1 Agonists - What is it? Mechanisms of Action and Therapeutic
Description
These disorders can be associated with insulin resistance, hyperglycemia-induced damage, oxidative stress, astrocyte abnormalities, and mitochondrial dysfunction, resulting in insufficient energy supply, altered synaptic plasticity, death of neuronal cells, as well as functional and structural damage to reward networks
Injection technique Currently, GLP-1RAs are only given by subcutaneous injection in Australia
251:351-364 [PubMed: 6361299] 426
This dual-pathway activity is one reason tirzepatide is often discussed as a stronger option for weight management
[PubMed ID: 31911298]
